Clinical Trial Update: Anti-TNF Agents for the Treatment of Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating anti-TNF agents for rheumatoid arthritis; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2015-04-14